Search

Current filters: HIV, Reproductive and maternal health, Research summary, Women

CATIE statement on the use of antiretroviral treatment (ART) to maintain an undetectable viral load as a highly effective strategy to prevent perinatal transmission of HIV

2020, CATIE
Research summary - Webpage

Decreasing the risk of neural tube defects with dolutegravir

From TreatmentUpdate 233
2019, CATIE
Research summary - Webpage

FDA warns that Prezcobix should not be used by HIV-positive pregnant women

From TreatmentUpdate 228
2018, CATIE
Research summary - Webpage

PrEP for understudied populations: Exploring questions about efficacy and safety

From Prevention in Focus - Fall 2018
2018, CATIE
Research summary - Webpage

Agencies issue caution about use of dolutegravir by pregnant HIV-positive women

2018, CATIE
Research summary - Webpage

Researchers study the impact of co-infection with hepatitis viruses on pregnant women with HIV

2018, CATIE
Research summary - Webpage

Views from the front lines: Pregnancy and infant feeding

From Prevention in Focus - Spring 2018
2018, CATIE
Research summary - Webpage

Pregnancy and infant feeding: Can we say U=U about the risk of passing HIV to an infant?

From Prevention in Focus - Spring 2018
2018, CATIE
Research summary - Webpage

Canadian researchers call for improved integration of family planning care for HIV-positive women

2017, CATIE
Research summary - Webpage

Quebec study is reassuring about the safety of HIV treatment during pregnancy

2017, CATIE
Research summary - Webpage